well the market has access to all of the reports and presentations that I have and then some. I use the bio tech analogy because of the inherent risks generally associated with investing in those companies. EOS is no different. If you don't believe me, just check the SP performance. Even prior to covid, the share price was on a downhill slide.
Go and read the EOS charts thread from the beginning and you'll see nothing but mad speculation. I agree and hope that the company will re-rate. But they're not deserving of a re-rate at this point in time.
Ann: Pause in Trading, page-87
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EOS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.60 |
Change
-0.065(3.92%) |
Mkt cap ! $307.7M | |||
| Open | High | Low | Value | Volume |
| $1.70 | $1.70 | $1.57 | $2.037M | 1.270M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 400 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.60 | 2659 | 1 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| EOS (ASX) Chart |